SZSE Releases
News
Market Brief
Companies
Releases
Pricing
Home
/
Companies
/
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
/
Release
002603
SZSE
Explanation by the Board of Directors on the Reasonableness of Provision for Asset Impairment
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
·
April 27, 2026
Full Translation